Immunogenicity, safety and duration of protection afforded by chikungunya virus vaccines undergoing human clinical trials. Rao S, Erku D, Mahalingam S, Taylor A, et al. J Gen Virol 2024;105.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Rao S, Erku D, Mahalingam S, Taylor A, et al. Immunogenicity, safety and duration of protection afforded by chikungunya virus vaccines undergoing human clinical trials. J Gen Virol 2024;105.
PMID: 38421278